Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
Apr 29, 2024
Abcam PLC
Cash from Investing Activities
|
Abcam PLC
Cash from Investing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Cash from Investing Activities
-£327.6m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-20%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is Abcam PLC's Cash from Investing Activities?
Cash from Investing Activities
-327.6m
GBP
-327.6m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Cash from Investing Activities amounts to -327.6m GBP.
What is Abcam PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-20%
-20%
Over the last year, the Cash from Investing Activities growth was -615%. The average annual Cash from Investing Activities growth rates for Abcam PLC have been -87% over the past three years , -58% over the past five years , and -20% over the past ten years .
You don't have any saved screeners yet
